Fastgen Corporation

Cardiac-2 Rapid Test

Troponin I /Myoglobin

NTENDED USE:   The Cardiac-2 Rapid Test is intended for the in vitro diagnostic use in the qualitative  detection  of cardiac Troponin I and Myoglobin in human serum samples.

Features and Advantages of Cardiac-2 Rapid Test

• Highly sensitive chromatographic immunoassay* offers the same features in the detection of Troponin I marker

• This test provides simultaneous detection of myoglobin, the first marker to rise above normal levels following cardiac necrosis associated with myocardial infarction (MI)

• Negative result in myoglobin detection may be used as a diagnostic aid in ruling out MI

• Rapid test format delivers results in minutes

*US FDA 510(K) approved pending 

Performance Characteristics

Cut-off positivity concentrations -	Troponin I	1.5 ng/ml
	Myoglobin	100 ng/ml

• Accuracy

Troponin I

	Negative (0 ng/ml)	Troponin I (0.3-0.8 ng/ml)	Troponin I  (≥1.1 ng/ml)
# Samples	105	23	67
Negative	104	23	0
Position	10	0	67
Agreement	99.1%	100%	100%

Myoglobin

	Negative (0 ng/ml)	Myoglobin (13-66 ng/ml)	Myoglobin  (100 ng/ml)
# Samples	70	50	101
Negative	70	42	0
Position	0	8	101
Agreement	100%	84%	100%

Product Information 

 in Acrobat (PDF)

Product Information 

 in Acrobat (PDF)

To Order

Catalog No. FGD0003    Cardiac-2 Rapid Test

Not available for sale in the US

Back